86
Views
13
CrossRef citations to date
0
Altmetric
Original Article

Sudden hearing loss in chronic hepatitis C patient suffering from Turner syndrome, treated with pegylated interferon and ribavirin

Hipoacusia súbita en un paciente con síndrome de Turner y hepatitis crónica C tratado con interferón pegilado y ribavirina

, , &
Pages 345-350 | Received 09 May 2006, Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

So Young Kim, Chang-Ho Lee, Chanyang Min, Hyung-Jong Kim & Hyo Geun Choi. (2020) Herpes zoster does not increase the risk of sudden sensory neural hearing loss: a longitudinal follow-up study using a national sample cohort. International Journal of Audiology 59:3, pages 173-178.
Read now
Mohamed Ibrahim Shabana, Ayman Rashad Amer, Abeir Osman Dabbous & Amani Ahmed Al-Sunni. (2010) Hearing profile in hepatitis C virus patients under dual treatment with interferon and ribavirin. Audiological Medicine 8:3, pages 142-153.
Read now

Articles from other publishers (11)

El-Zahraa M. Meghezel, Mohammed A. Abd Al-Ghaffar, Asmaa Naser Mohammad, Samar M. Mahmoud, Usama M. Abdelaal & Salwa Mourad. (2022) Assessment of auditory function in hepatitis “C” patients managed by combination of sofosbuvir and daclatsavir. The Egyptian Journal of Otolaryngology 38:1.
Crossref
Lorena Carvalho Cavalcanti Lagreca, Edison Roberto Parise, João Luiz Rodrigues de Farias, Cristiana Corvaro & Marisa Frasson de Azevedo. (2022) Avaliação audiológica em pacientes com hepatite C crônica tratados por antivirais de ação direta. Audiology - Communication Research 27.
Crossref
Christine LittleMaura K. Cosetti. (2021) A Narrative Review of Pharmacologic Treatments for COVID ‐19: Safety Considerations and Ototoxicity . The Laryngoscope 131:7, pages 1626-1632.
Crossref
Elshahat Ibrahem Ismail, Ashraf Elsayed Morgan & Raghda Elsayed Farag. (2018) Assessment of auditory functions in chronic hepatitis C patients treated by sofosbuvir. Journal of Otology 13:1, pages 10-15.
Crossref
Samir Asal, Ossama Sobhy, Omneya Ismail & Essam Bedewy. (2015) Study of the effect of combined interferon and ribavirin therapy on the hearing profile of hepatitis C virus patients. The Egyptian Journal of Otolaryngology 31:4, pages 237-243.
Crossref
S A Sara, B M Teh & P Friedland. (2013) Bilateral sudden sensorineural hearing loss: review. The Journal of Laryngology & Otology 128:S1, pages S8-S15.
Crossref
Savita Jain, Vandana Midha & Ajit Sood. (2011) Unilateral hearing loss due to pegylated interferon-α2b and ribavirin therapy. Indian Journal of Gastroenterology 30:5, pages 239-240.
Crossref
Gulden Eser Karlidag, Turgut Karlidag, Kutbettin Demirdag & Erol Keles. (2011) The effects of pegylated interferon/lamivudine therapy on auditory functions in patients with chronic hepatitis B. Auris Nasus Larynx 38:3, pages 312-318.
Crossref
Takuya Kitada, Takashi Narimatsu & Seiko Yamaguchi. (2009) Sudden hearing loss in a patient with chronic hepatitis C treated with pegylated interferon α2a and ribavirin. Kanzo 50:7, pages 371-376.
Crossref
Vu Le, Ted Bader & Javid Fazili. (2008) A case of hearing loss associated with pegylated interferon and ribavirin treatment ameliorated by prednisone. Nature Clinical Practice Gastroenterology & Hepatology 6:1, pages 57-60.
Crossref
. (2008) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 17:3.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.